GLOW Peptide Blend
Proprietary blend targeting skin luminosity, elasticity, and repair.
5 mg/day (standard topical research dose)
Key Benefits
combines three peptide actives that each target a different aging mechanism for results no single ingredient can achieve
GHK-Cu and Matrixyl together increase structural protein synthesis, restoring skin firmness and reducing wrinkle depth by up to 36%
supports epidermal integrity and moisture retention, reducing transepidermal water loss in aging skin models
addresses dullness at the cellular level by improving cell turnover, reducing oxidative pigmentation, and enhancing light reflection
Recommended Injection Sites
Optimal injection locations for GLOW Peptide Blend based on its route (Topical or subcutaneous) and pharmacokinetic profile.
Tap a glowing zone on the body map to highlight the matching site card — or tap a card to activate the zone.
Tap a zone to inject
Primary research route. Dissolve in carrier solution (DMSO/saline blend or cosmetic vehicle). Apply to clean, dry skin. Massage gently to aid absorption.
For systemic skin research protocols requiring SubQ delivery. Standard SubQ technique.
Alternative SubQ site for systemic administration.
For topical use, apply to target area daily. For SubQ, rotate abdominal quadrants to prevent local peptide accumulation.
- IV administration
- Application to broken or irritated skin
- Eyes and mucous membranes
Active Signaling Pathway
GLOW combines three peptide actives targeting different skin aging mechanisms: GHK-Cu for gene expression reset, Matrixyl (palmitoyl pentapeptide-4) for structural collagen, and Leuphasyl for reducing muscle contraction intensity at expression lines.
Recommended Stacks
GLOW Peptide Blend is a key compound in these curated research stacks. Pair it with synergistic peptides for enhanced outcomes.
Radiant Skin & Anti-Aging
Target every layer of skin aging simultaneously — structural, regenerative, and oxidative.
Total Beauty & Wellness
Inside-out beauty — combining skin repair with the systemic anti-aging compounds that make skin glow from within.
How long will one vial last?
Based on standard research protocols, here's exactly what to expect from a single 70mg vial — and when to plan your next order.
Actual duration may vary based on your specific protocol. Always consult your research guidelines for precise dosing schedules.
Scientific Background
Mechanism of Action
GLOW combines three synergistic peptide actives: GHK-Cu activates collagen and elastin gene expression via copper-mediated signaling; Matrixyl (Palmitoyl Pentapeptide-4) mimics collagen breakdown fragments to trigger repair synthesis via TGF-β pathway; Leuphasyl inhibits neuronal acetylcholine release at the dermal-muscular junction, reducing expression lines. Together they address structural, regenerative, and dynamic aging simultaneously.
Clinical Context
The GLOW blend is formulated for topical research applications targeting the full spectrum of skin aging: loss of structural proteins (collagen/elastin), reduced regenerative signaling, and dynamic wrinkle formation. The 70mg vial provides sufficient material for extended topical research protocols.
Research Highlights
- Matrixyl (Pal-KTTKS) shown in double-blind clinical study to reduce wrinkle volume by 36% over 12 weeks
- GHK-Cu component increases collagen synthesis by up to 70% in fibroblast cultures
- Leuphasyl demonstrated 45% reduction in muscle contraction intensity in in vitro neuromuscular junction models
- Multi-peptide synergy studies show greater efficacy than any single component alone for skin density improvement
Storage & Reconstitution
Topical application in a carrier solution is the primary research route for skin studies. Dissolve in sterile saline.